Michael Søberg Christensen

Global Portfolio VP @ Novo Nordisk

Country

Denmark

City

Copenhagen

Industry

Pharmaceuticals

Skill

Obesity Treatment, Strategic Leadership, GxP, Leadership, Good Clinical Practice (GCP), Digital Strategy, Board of Directors, Bioanalysis, Clinical Development, Biotechnology, Clinical Trials, DMPK, Pharmaceutical Industry, Regulatory Affairs, Drug Development, CMC, Regulatory Submissions, Life Sciences, Diabetes, Biopharmaceuticals

Experience

Global Portfolio VP

Novo Nordisk

2025-12 - Present · 10 mos

Corporate Vice President, Head of Global Regulatory Affairs

Novo Nordisk

2018-9 - 2025-11 · 7 yrs 3 mos

Corporate Vice President, Global Regulatory Affairs, RA CMC & Device

Novo Nordisk

2017-2 - 2018-8 · 1 yr 7 mos

Corporate Vice President, Global Regulatory Affairs, RA CMC

Novo Nordisk

2014-10 - 2017-1 · 2 yrs 4 mos

Soeborg, Denmark

Corporate Project Vice President, Inflammation&GH

Novo Nordisk

2013-10 - 2014-9 · 1 yr

Soeborg, Denmark

Acting Corporate Vice President, Inflammation & GH

Novo Nordisk

2013-4 - 2013-10 · 7 mos

Project Vice President, Inflammation

Novo Nordisk

2011-12 - 2013-4 · 1 yr 5 mos

Project Vice President, GLP-1 & Obesity

Novo Nordisk

2010-2 - 2011-12 · 1 yr 11 mos

Acting Corporate Vice President, Nonclinical Development

Novo Nordisk

2008-8 - 2010-2 · 1 yr 7 mos

Director, DMPK & Bioanalysis

Novo Nordisk

2007-1 - 2008-8 · 1 yr 8 mos

Head of Department, Drug Metablism & Pharmacokinetics

Novo Nordisk

2005-8 - 2007-1 · 1 yr 6 mos

Head of Department, Drug Metabolism

Novo Nordisk

2001-8 - 2005-8 · 4 yrs 1 mo

Section Head, Exploratory ADME

Novo Nordisk

2000-1 - 2001-8 · 1 yr 8 mos

Maaloev, Denmark

Research Scientist

Novo Nordisk

1996-2 - 1999-12 · 3 yrs 11 mos

Education

DTU - Technical University of Denmark

Biochemistry

1984 - 1994 · 10 yrs